CD80 and non-small cell lung carcinoma: Moreover, homoharringtonine induced changes in immune cell features by decreasing the expression level of IL12 and the overexpression of CD80, CD86, CD69, CD80+, and CD86−in B220 + B cells and B cells, respectively, in non-small cell lung cancer.